Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The International Journal of Neuropsychopharmacology|June 14, 2014
TAAR1-dependent effects of apomorphine in miceIlya Sukhanov, Stefano Espinoza, Dmitriy S Yakovlev, et al.
Neuropharmacology|February 28, 2015
Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1Stefano Espinoza, Valentina Ghisi, Marco Emanuele, et al.
Cellular and Molecular Neurobiology|November 18, 2019
The Action of TAAR1 Agonist RO5263397 on Executive Functions in RatsArtem Dorotenko, Margarita Tur, Antonina Dolgorukova, et al.
Pharmacological Research|December 8, 2015
Increased context-dependent conditioning to amphetamine in mice lacking TAAR1Ilya Sukhanov, Lucia Caffino, Evgeniya V Efimova, et al.
Neuropharmacology|July 19, 2005
Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in ratsAnton Y Bespalov, Olga A Dravolina, Ilya Sukhanov, et al.
Frontiers in Psychiatry|April 4, 2022
The Lack of Dopamine Transporter Is Associated With Conditional Associative Learning Impairments and Striatal Proteomic ChangesArtem Savchenko, Carina Müller, Jana Lubec, et al.
Biomolecules|January 21, 2023
Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson's Disease TherapyIlya Sukhanov, Artem Dorotenko, Zoia Fesenko, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological AssaysElena Cichero, Valeria Francesconi, Beatrice Casini, et al.
Frontiers in Pharmacology|September 21, 2018
Behavioral Effects of a Potential Novel TAAR1 AntagonistVincent M Lam, Catharine A Mielnik, Corey Baimel, et al.
Biomolecules|November 11, 2022
Discovery of Trace Amine Associated Receptor 1 (TAAR1) Agonist 2-(5-(4'-Chloro-[1,1'-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic DisordersMikhail Krasavin, Alexey Lukin, Ilya Sukhanov, et al.
Pageof 3